CurePSP Support Group Initiative Goes Global This Giving Tuesday.

Categories: Uncategorized

This press release was published at 10am Wednesday, November 15, in PR Newswire.   NEW YORK, Nov. 15, 2017 /PRNewswire/ — CurePSP, the leading nonprofit advocacy organization for prime of life neurodegenerative diseases, today announced the launch of a global initiative tied to Giving Tuesday, #PiesforPSP, to support individuals and families who have been affected by …

Read More

New Criteria For PSP Diagnosis

Categories: Uncategorized

New Diagnosis Criteria Established for PSP. In a groundbreaking development, an international collaboration of neurologists and movement disorder specialists have convened to agree on a a revision of the previous PSP diagnostic criteria. CurePSP has worked closely with many of the collaborators involved, and is very excited about this new development. “The new diagnostic criteria are …

Read More

Why Advocacy is Vital

Categories: Support News, Uncategorized, Volunteer

In this article, Trish Caruana, Vice President – Patient and Carepartner Advocacy explains what advocacy is, and the common hurdles people face when considering advocacy. Care, consciousness and cure are central to the mission of CurePSP, but how we advocate for people with PSP and other prime of life diseases is also important. The lack of …

Read More

Anti-Tau Antibody Trial Enters Phase 2!

Categories: Uncategorized

AbbVie Initiates Phase 2 Clinical Trial Programs for ABBV-8E12, an Investigational Anti-Tau Antibody, in Early Alzheimer’s Disease and Progressive Supranuclear Palsy Jan 25, 2017 Courtesy of AbbVie, January 2017   – Initiation of Phase 2 clinical trial programs in early Alzheimer’s disease and progressive supranuclear palsy (PSP) is part of ongoing commitment to investigate ABBV-8E12 …

Read More

CurePSP Receives Matching Grant Challenge for Genetics Research

Categories: Research News, Uncategorized

Friedman family has committed up to $600,000 New York, NY (June 29, 2016) — CurePSP, the leading nonprofit advocacy organization focused on prime of life neurodegenerative diseases, today announced a matching grant challenge of up to $600,000 from the Friedman family to accelerate genetics research. An initial contribution of $250,000 toward this goal has been …

Read More